Venus Medtech (Hangzhou) Inc. (02500) reported that, as of 31 October 2025, its total share capital remained at RMB 441,011,443, comprising 441,010,235 H shares listed on the Hong Kong Stock Exchange and 1,208 unlisted foreign shares. No changes were recorded in the issued share capital compared to the preceding month.

No share options were exercised and no additional shares were issued or repurchased in October 2025. A total of 3,114,000 H shares repurchased in December 2021 remain uncancelled as of 31 October 2025. No conversions under other financial instruments or treasury share transfers occurred during the reporting period.

According to the announcement, all relevant approvals and regulations for previously conducted share transactions have been duly observed. The concept of "authorized share capital" does not apply in the issuer’s home jurisdiction, and references in the disclosure refer to its issued share capital.